QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Mural Oncology plc (NASDAQ:MURA) ("Mural") today announced that its shareholders have voted to approve the previously a...

Core News & Articles

- Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary ge...

 xoma-royalty-may-offer--sell-shares-of-common-stock-from-time-to-time-of-up-to-75m

-SEC Filing

Core News & Articles

EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (&...

Core News & Articles

Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.1...

Core News & Articles

Under the terms of the Merger Agreement, HilleVax stockholders will receive $1.95 in cash per share of HilleVax common stock at...

 hc-wainwright--co-reiterates-buy-on-xoma-royalty-maintains-104-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:XOMA) with a Buy and maintains $104 price t...

 benchmark-initiates-coverage-on-xoma-royalty-with-buy-rating-announces-price-target-of-35

Benchmark analyst Robert Wasserman initiates coverage on XOMA Royalty (NASDAQ:XOMA) with a Buy rating and announces Price Ta...

 hc-wainwright--co-reiterates-buy-on-xoma-royalty-maintains-104-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:XOMA) with a Buy and maintains $104 price t...

 hc-wainwright--co-reiterates-buy-on-xoma-royalty-maintains-104-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:XOMA) with a Buy and maintains $104 price t...

 xoma-q4-2024-gaap-eps-045-misses-030-estimate-sales-871m-miss-875m-estimate

XOMA (NASDAQ:XOMA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.30) by 50 ...

Core News & Articles

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in exchang...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION